Medical Cannabis Production
CINV is a pioneering licensed company specialising in cultivating and distributing cannabis-based products for medicinal use (CBPMs).
Countries have now legalised the use of medical cannabis
We are dedicated to exploring and advancing genetics with full-spectrum terpenes and cannabinoids. We believe that quality CBPMs should be consistently accessible to all patients globally.
Business Model Highlights
Seed-to-Patient Oversight
Our seed-to-patient framework sets a new standard for cannabis-based products for medicinal use (CBPMs). We have built a framework that facilitates the entire cultivation, processing, distribution to patient journey that gives us complete oversight of our medical cannabis supply chain. Our goal is ensure that our CBPMs exceed expectations and reach the end-user without compromising on quality.
Cultivation and Expertise
Our cultivars are grown by our team of world-class genetic specialists with decades of combined experience. Our team conducts pheno-hunting, sourcing sought-after genetics and utilising advanced cultivation techniques to produce terpene-rich, effective CBPMs for a wide range of medical conditions.
Rigorous Testing and Supply Chain Oversight
Every strain undergoes thorough laboratory testing to gain Certificates of Analysis (COAs). and we maintain full oversight of the supply chain including our growers, secure packaging processes, import/export and rigorous quality testing to deliver safe and effective products.
World-Class Product Safety
We strictly adhere to Good Manufacturing Practices (GMP) and EU-GMP requirements to guarantee the highest level of safety and quality for our CBPMs, ensuring that patients receive consistent, reliable products.
Breaking the Medical Cannabis Stigma
There is still a huge stigma to overcome in the medical cannabis industry. We leverage our patient-facing brand to deliver honest, simplified, science-backed information that empowers and provides clarity.
Expanding Patient Access to CBPMs
We are committed to expanding patient access through our strategic partnership with Cantourage, the leading UK & European medical cannabis clinic in the UK and Europe. Cantourage checks patient eligibility and provides clear registration guidance, ensuring a smooth and supportive process for those seeking CBPMs.
Investor Confidence
CINV's vertically integrated model and growing production capacity, supported by collaborations with experts like Ember Pharms, are solidifying our place as a leader in the global medical cannabis market. This innovative approach, combined with strict adherence to safety standards and sustainability, ensures confidence for both patients and investors.
Putting Patients First
Our business model is centred around patient care, ensuring we never over promise medication availability. By maintaining a consistent and reliable supply, we guarantee that patients who are prescribed CBPMs receive their full, prescribed dose, supporting continuity of care and fostering trust in treatment.
Our cultivation techniques produce premium cannabis flower with remarkable structure, yields, THC levels, and terpene profiles.
Through our exceptional genetics and strategic alliances, we are poised to supply the pharmaceutical industry with unparalleled GMP- Flower and GMP-Oil.
From Seed to
Patient: Our Cannabis Journey
Learn how our award-winning techniques produce exceptional cannabis genetics optimized for safety, consistency, and efficacy.
